Abstract
Purpose
To validate the Impact Index, a short, publicly available scale that measures the extent to which a respondent’s health problem adversely impacts their quality of life.
Methods
Secondary analysis of patients with hip or knee osteoarthritis surveyed after visiting a surgeon at baseline (N = 322) and about 6 months after the visit (N = 283). Patients responded to the Impact Index and previously validated questionnaires about overall health, pain, and function. The Impact Index includes four questions that ask how much the respondent is bothered, worried, limited, or in pain due to their health condition over the past 30 days. Total scores range from 0 to 12; higher scores indicate more deleterious impact.
Results
Patients were mostly female (55%), majority white (95%), had an average age of 65 (SD = 9), and most had surgery (64%). The baseline Impact Index score was 9.48 (SD = 2.63); at follow up 4.75 (SD = 3.54). Impact Index was related to overall health at baseline (r = − 0.49). For knee patients at baseline, Impact Index was negatively related to their knee symptoms (r = − 0.49) and knee pain (r = − 0.67). For hip patients at baseline, Impact Index was negatively related to the Harris Hip score (r = − 0.62). Scale directions varied; however, the signs of all correlations were as hypothesized. The Impact Index was predictive of surgical choice (p < .001, OR = 1.45), however, overall health (p = .88) and comorbidity (p = .24) measures were not. Reliability was acceptable (α = 0.85). Responsiveness statistics suggested overall health, pain, function, and Impact Index measures reflected improvement patients experienced from surgery. The Impact Index had the largest effect sizes (> − 3.4) and Guyatt Responsiveness Statistics (> − 2.3).
Conclusions
The Impact Index demonstrated strong evidence of validity, reliability, and responsiveness in hip or knee osteoarthritis patients.
Similar content being viewed by others
Data availability
Data can be accessed by contacting Drs. Barry or Sepucha and completing the necessary Institutional Review Board and data use agreements.
Code availability
All analytic code is provided in an R markdown document located in the Open Science Framework Repository here: osf.io/hrwp4.
References
Black, N. (2013). Patient reported outcome measures may transform healthcare. BMJ, 346(7896), 19–21.
Nelson, E. C., Eftimovska, E., Lind, C., Hager, A., Wasson, J. H., & Lindblad, S. (2015). Patient reported outcome measures in practice. BMJ, 350, 1–3.
Patrick, D. L., & Deyo, R. A. (1989). Generic and disease-specific measures in assessing health status and quality of life. Medical Care, 27, S217–S232.
Barry, M. J., et al. (1995). Measuring disease-specific health status in men with benign prostatic hyperplasia. Medical Care, 33, AS145–AS155.
Fowler, F. J., Jr., & Barry, M. J. (1993). Quality of life assessment for evaluating benign prostatic hyperplasia treatments. European Urology, 24, 24–27.
Fowler, F. J., Collins, M. M. N., Corkery, E. W., Elliott, D. B., & Barry, M. J. (2002). The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma. Cancer, 95(2), 287–295.
Sepucha, K., et al. (2019). Decision Support Strategies for hip and knee osteoarthritis: Less is more. A randomized comparative effectiveness trial (DECIDE-OA study). Journal of Bone and Joint Surgery of America, 101(18), 1645–1653.
Mangla, M., et al. (2019). Protocol for a randomised trial evaluating the comparative effectiveness of strategies to promote shared decision making for hip and knee osteoarthritis (DECIDE-OA study). British Medical Journal Open, 9(2), 1–12.
Rabin, R., & Charro, F. D. (2001). EQ-SD: A measure of health status from the EuroQoL Group. Annals of Medicine, 33(5), 337–343.
Jansson, K. Å., & Granath, F. (2011). Health-related quality of life (EQ-5D) before and after orthopedic surgery. Acta Orthopaedica, 82(1), 82–89.
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373–383.
Roos, E. M., & Lohmander, L. S. (2003). The Knee injury and Osteoarthritis Outcome Score (KOOS): From joint injury to osteoarthritis. Health and Quality of Life Outcomes, 1(64), 1–8.
Collins, N. J., & Roos, E. M. (2012). Patient-reported outcomes for total hip and knee arthroplasty: Commonly used instruments and attributes of a ‘good’ measure. Clinics in Geriatric Medicine, 28(3), 367–394.
Lyman, S., Lee, Y. Y., Franklin, P. D., Li, W., Cross, M. B., & Padgett, D. E. (2016). Validation of the KOOS, JR: A Short-form Knee Arthroplasty Outcomes Survey. Clinical Orthopaedics and Related Research, 474(6), 1461–1471.
KOOS, Jr Scoring Instructions. (2017). https://www.hss.edu/files/KOOS-JR-Scoring-Instructions-2017.pdf. Accessed 10 Dec 2020.
Nilsdotter, A., & Bremander, A. (2011). Measures of hip function and symptoms: Harris Hip Score (HHS), Hip Disability and Osteoarthritis Outcome Score (HOOS), Oxford Hip Score (OHS), Lequesne Index of Severity for Osteoarthritis of the Hip (LISOH), and American Academy of Orthopedic Surgeons (AAOS) Hip and Knee Questionnaire. Arthritis Care and Research, 63(Suppl. 11), 200–207.
Söderman, P., & Malchau, H. (2001). Is the Harris Hip Score system useful to study the outcome of total hip replacement? Clinical Orthopaedics and Related Research, 384, 189–197.
Bedson, J., & Croft, P. R. (2008). The discordance between clinical and radiographic knee osteoarthritis: A systematic search and summary of the literature. BMC Musculoskeletal Disorders, 9, 1–11.
Bastick, A. N., et al. (2016). Defining knee pain trajectories in early symptomatic knee osteoarthritis in primary care: 5-Year results from a nationwide prospective cohort study (CHECK). British Journal of General Practice, 66(642), e32–e39.
Husted, J. A., Cook, R. J., Farewell, V. T., & Gladman, D. D. (2000). Methods for assessing responsiveness: A critical review and recommendations. Journal of Clinical Epidemiology, 53(5), 459–468.
De Morton, N. A., Davidson, M., & Keating, J. L. (2011). Reliability of the de Morton mobility index (DEMMI) in an older acute medical population. Physiotherapy Research International, 16(3), 159–169.
Goodman, S. M., et al. (2020). Validation of the hip disability and osteoarthritis outcome score and knee injury and osteoarthritis outcome score pain and function subscales for use in total hip replacement and total knee replacement clinical trials. Journal of Arthroplasty, 35(5), 1200-1207.e4.
Lyman, S., Lee, Y. Y., McLawhorn, A. S., Islam, W., & MacLean, C. H. (2018). What are the minimal and substantial improvements in the HOOS and KOOS and JR versions after total joint replacement? Clinical Orthopaedics and Related Research, 476(12), 2432–2441.
Acknowledgements
The study was funded in part through a Patient-Centered Outcomes Research Institute® (PCORI) Award (CDR#1503-28799). The funding agreement ensured the authors’ independence in designing the study, interpreting the data, writing, and publishing the report. Drs. Barry’s and Brodney’s time were funded in part through a grant from Healthwise, Incorporated, a nonprofit.
Author information
Authors and Affiliations
Contributions
Each author has contributed significantly to, and is willing to take public responsibility for, one or more aspects of the study. All authors have been actively involved in the drafting and critical revision of the manuscript, and each has provided final approval of the version submitted. Study design: HV, KS. Data acquisition: HV, KS. Analysis and interpretation: KDV, SB, HV, KS, FF, MJB. Drafting and critical revision of the manuscript: KDV, SB, HV, KS, FF, MJB.
Corresponding author
Ethics declarations
Conflict of interest
With regards to potential conflicts of interest for this study. Drs. Fowler and Valentine have no conflicts of interest to disclose. Both Drs. Barry and Brodney receive Grant funding through Massachusetts General Hospital from Healthwise, a nonprofit.
Ethical approval
Partners Human Research Committee was the Central Institutional Review Board for the study. The DECIDE-OA study is registered on Clinicaltrials.gov (# NCT02729831).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Valentine, K.D., Brodney, S., Vo, H. et al. Validation of the Impact Index: can we measure disease effects on quality of life in patients with hip and knee osteoarthritis?. Qual Life Res 30, 1191–1198 (2021). https://doi.org/10.1007/s11136-020-02728-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-020-02728-7